These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1388757)

  • 1. Formulation aspects on dermatological preparations and transdermal drug delivery systems.
    Junginger HE
    Acta Pharm Nord; 1992; 4(2):117. PubMed ID: 1388757
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of pharmaceutical formulation for dermatological preparations.
    Ross G
    Boll Chim Farm; 1981 Aug; 120(8):437-57. PubMed ID: 7317170
    [No Abstract]   [Full Text] [Related]  

  • 3. Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents.
    Bikowski J; Shroot B
    J Drugs Dermatol; 2006; 5(10):942-6. PubMed ID: 17373142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug storage and administration references. Drugs for cutaneous administration].
    Kircher W
    Med Monatsschr Pharm; 1990 Jun; 13(6):187-90. PubMed ID: 2374514
    [No Abstract]   [Full Text] [Related]  

  • 6. [Topical therapy in dermatology: pharmaceutical forms, excipients and bases for magistral preparations].
    Vennat B; Pouget MP; Pourrat A
    Ann Dermatol Venereol; 2000 Jan; 127(1):110-21. PubMed ID: 10717577
    [No Abstract]   [Full Text] [Related]  

  • 7. Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist.
    Potts RO; Lobo RA
    Obstet Gynecol; 2005 May; 105(5 Pt 1):953-61. PubMed ID: 15863530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Considerations on dermatological magistral preparations].
    Oslet J
    J Pharm Belg; 1966; 21(3):163-202. PubMed ID: 5914546
    [No Abstract]   [Full Text] [Related]  

  • 11. Transdermal delivery systems.
    Merkle HP
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):135-53. PubMed ID: 2657273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of topical delivery of methotrexate by electroporation.
    Wong TW; Zhao YL; Sen A; Hui SW
    Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acne therapy.
    White GM
    Adv Dermatol; 1999; 14():29-58; discussion 59. PubMed ID: 10643494
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dermatological treatment].
    Battyáni Z
    Orv Hetil; 2006 Dec; 147(51):2475-80. PubMed ID: 17378167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transdermal therapeutic systems (TTS)].
    Niedner R
    Hautarzt; 1988 Dec; 39(12):761-6. PubMed ID: 2976752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aerosol cans--a new method of application of dermatological preparations].
    Tsetlin VM; Eĭdel'shteĭn SI
    Vestn Dermatol Venerol; 1968 Feb; 42(2):30-3. PubMed ID: 5741226
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of transdermal nicotine patches for eosinophilic pustular folliculitis.
    Kanekura T; Mera Y; Mera K; Saruwatari H; Kanzaki T
    Br J Dermatol; 2005 May; 152(5):1074-5. PubMed ID: 15888180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.